Kate Bechtold | Senior Director, IR |
Liz Barrett | President & CEO |
Mark Schoenberg | Chief Medical Officer |
Jeff Bova | SVP, Commercial |
Peter Pfreundschuh | CFO |
Boris Peaker | Cowen |
Leland Gershell | Oppenheimer |
Paul Choi | Goldman Sachs |
Matt Kaplan | Ladenburg Thalmann |
Thank you for standing by and welcome to the UroGen Pharma Second Quarter 2020 Financial Results and Business Update Conference Call. At this time, all participants in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator instructions] Please be advised that today's conference is being recorded. [Operator instructions] I would not like to hand the conference over to your speaker today to Peter Pfreundschuh, CFO.